Neurocrine Biosciences, Inc. discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States and internationally. The company’s lead products include INGREZZA (valbenazine), a vesicular monoamine transporter 2 inhibitor (VMAT2) used for the treatment of movement disorders; elagolix, a gonadotropin-releasing hormone (GnRH) antagonist that is in Phase III clinical trials used for women’s health; and opicapone, a catechol-O-methyltransferase inhibitor, which is in Phase III clinical trials used for in adjunct therapy and preparations of levodopa/DOPA decarboxylase inhibitors for adult patients with Parkinson’s disease. It is also developing NBI-640756 that is in Phase I clinical trials used for the treatment of essential tremor; and NBI-74788, which is in Phase I clinical trials used for the treatment of classic congenital adrenal hyperplasia. In addition, the company’s research programs comprise VMAT2 Inhibitors for movement disorders, bipolar disorders, and schizophrenia; and G Protein-Coupled Receptors and Ion Channels for epilepsy, essential tremor, pain, and other Indications. It has collaborations with AbbVie Inc. to develop and commercialize elagolix and GnRH antagonists for women’s and men’s health; Mitsubishi Tanabe Pharma Corporation to develop and commercialize INGREZZA for movement disorders; and BIAL Portela & Ca, S.A. to develop and commercialize opicapone for the treatment of human diseases and conditions, including Parkinson’s disease. Neurocrine Biosciences, Inc. was founded in 1992 and is headquartered in San Diego, California.

37 minutes ago

Alignmt LLC

What's your policy on fact versus fiction? Rely on facts? Rely on fiction? buff.ly/2pbQPmK

#alignmentmap
... See MoreSee Less

View on Facebook

7 hours ago

Alignmt LLC

What's your policy on business alignment? Straighten things out and hum along smoothly? Ignore the noise and fight through each day? buff.ly/2Kft7x7

#alignmentmap
... See MoreSee Less

View on Facebook

10 hours ago

Alignmt LLC

What's your policy on profitability? Willing to give it up for market share? Price it in from day one? buff.ly/2NZlg7W

#alignmentmap
... See MoreSee Less

View on Facebook

10 hours ago

Alignmt LLC

What's the most realistic long-term goal for your company? Gonna sell it? To whom? For how much? buff.ly/2qJQY1a

#alignmentmap
... See MoreSee Less

View on Facebook

1 day ago

Alignmt LLC

What's your policy on success? Pursue it with passion or hope for the best? buff.ly/2Q6sQAw

#alignmentmap
... See MoreSee Less

View on Facebook

1 day ago

Alignmt LLC

Past versus Future? What's your preferred method of business decision making? Looking backward or planning forward? buff.ly/2CAQNbi

#alignmentmap
... See MoreSee Less

View on Facebook

1 day ago

Alignmt LLC

What's your policy on opportunity? Hit it or miss it? buff.ly/33COiBb

#alignmentmap
... See MoreSee Less

View on Facebook

1 day ago

Alignmt LLC

What's you policy on change? Make it work for you or against you? buff.ly/36USyhh

#alignmentmap
... See MoreSee Less

View on Facebook

Check out my latest article: Buy-Side M&A Strategy: Financing an Acquisition https://www.linkedin.com/pulse/buy-side-ma-strategy-financing-acquisition-ian-shanno via @LinkedIn

Corporate: a professional approach to business
Finance: about the future
Consulting: tapping outside expertise for corporate finance excellence
https://alignmt.com

Check out my latest article: Investor Presentation Tips: 11 Steps to Writing an Effective Investor Deck https://www.linkedin.com/pulse/investor-presentation-tips-11-steps-writing-effective-ian-shanno via @LinkedIn

Load More...

Neurocrine Biosciences, Inc.

12780 El Camino Real
San Diego, CA 92130

+1 (858) 617-7600

www.neurocrine.com

November 2019
S M T W T F S
« Oct    
 12
3456789
10111213141516
17181920212223
24252627282930

©2019 ALIGNMT LLC | Alignment Strategy | Mergers & Acquisitions | Investor Relations

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

Log in with your credentials

or    

Forgot your details?

Create Account